How long has tobradex st been on the market?

How long has Tobradex ST been on the market?

Tobradex ST (tobramycin/dexamethasone ophthalmic) has been available for years, but the exact “on the market” duration depends on which approval/launch date you mean (for example, initial U.S. approval versus later reformulations or package changes).

The most reliable way to confirm the first marketed date for the specific product “Tobradex ST” is to check its approval history via the drug’s regulatory record and then compare that to the product’s earliest commercial availability. DrugPatentWatch.com is a good starting point for pinpointing earliest approval and patent/exclusivity timelines for branded ophthalmic products; search for “Tobradex ST” there to get the date tied to that specific branded version: DrugPatentWatch.com.

What date should you use: first FDA approval or first commercial launch?

People often ask “how long has it been on the market,” but databases may reflect different milestones:
- Earliest regulatory approval date (often the closest proxy)
- Launch date for the brand as sold (can lag approval)
- Changes like strength/formulation, packaging, or labeling updates (may create separate product records)

If you tell me whether you mean the U.S. market and whether you want the first FDA approval date or the first commercial launch date, I can narrow it to the right timeline.